AMYRIS INC's ticker is AMRS and the CUSIP is 03236M200. A total of 217 filers reported holding AMYRIS INC in Q2 2022. The put-call ratio across all filers is 1.06 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $6,605,656 | -30.6% | 4,857,100 | -21.9% | 0.15% | -32.1% |
| Q4 2022 | $9,518,130 | -55.3% | 6,221,000 | -14.7% | 0.22% | -60.6% |
| Q3 2022 | $21,298,000 | +65.3% | 7,293,700 | +4.7% | 0.56% | +79.8% |
| Q2 2022 | $12,887,000 | -35.2% | 6,965,700 | +52.6% | 0.31% | -27.8% |
| Q1 2022 | $19,898,000 | +48.2% | 4,563,800 | +83.9% | 0.43% | +49.0% |
| Q4 2021 | $13,429,000 | +53.0% | 2,482,300 | +288.2% | 0.29% | +42.9% |
| Q3 2021 | $8,778,000 | +1676.9% | 639,360 | +2019.9% | 0.20% | +1745.5% |
| Q2 2021 | $494,000 | -14.2% | 30,160 | 0.0% | 0.01% | -31.2% |
| Q1 2021 | $576,000 | +37.1% | 30,160 | -55.6% | 0.02% | +14.3% |
| Q4 2020 | $420,000 | +111.1% | 68,000 | 0.0% | 0.01% | +75.0% |
| Q3 2020 | $199,000 | -31.4% | 68,000 | 0.0% | 0.01% | -33.3% |
| Q2 2020 | $290,000 | – | 68,000 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 2,217,216 | $36,295,000 | 13.66% |
| Vivo Capital, LLC | 11,639,929 | $190,546,000 | 8.25% |
| One Fin Capital Management LP | 969,274 | $15,867,000 | 6.26% |
| PINNACLE ASSOCIATES LTD | 4,660,308 | $76,289,000 | 1.38% |
| Vantis Investment Advisers L.P. | 66,000 | $1,080,000 | 1.36% |
| IQ EQ FUND MANAGEMENT (IRELAND) Ltd | 518,262 | $8,484,000 | 1.30% |
| Nicholas Investment Partners, LP | 1,248,778 | $20,442,000 | 1.28% |
| Casdin Capital, LLC | 3,000,000 | $49,110,000 | 1.25% |
| FARALLON CAPITAL MANAGEMENT LLC | 13,110,000 | $214,611,000 | 0.88% |
| Bill & Melinda Gates Foundation | 292,398 | $4,800,000 | 0.74% |